Matthew Olson, PhD

Head of Assay Development + Target Strategy

• Former Head Assay Development and Principal Scientist at HemoShear Therapeutics

• Developed novel and critical biomarker assays for internal and external programs including Phase II asset

• Developed novel assays for each internal and external program.

• Multiple patent applications and approvals

• Director External Innovation at Janssen Pharmaceuticals

• Identified novel chemical and biological platforms.

• Created partnerships and relationships enhance internal drug discovery.

• Site Lead for Epigenetics Initiative

• Principal Scientist II at Wyeth

• Project team leader in infectious disease

• Team member for multiple IND filings